BIOETHICS

Cohen, I. G., & Lynch, H. F. (2014). Human Subjects Research Regulation: Perspectives on the Future. United Kingdom: MIT Press.

Committee on the Judiciary (1998), Subcommittee on Technology, Terrorism, and Government Information, to hold hearings to examine incidences of foreign terrorists in America five years after the world Trade Center, 9 a.m., SD–226.

Donohue, J. (2006). A history of drug advertising: the evolving roles of consumers and consumer protection. The Milbank Quarterly, 84(4), 659-699.

Gorsuch, N. M. (2006). The Future of Assisted Suicide and Euthanasia. Princeton University Press. 

Green, M. D., & Schultz, W. B. (1999). Tort law deference to FDA regulation of medical devices. Geo. LJ, 88, 2119.

Hardin, G. (1968). The Tragedy of the Commons. Science, VOL. 162, pp.1243-1248.

Kapczynski, A. (2018). The Lochnerized First Amendment and the FDA: Toward a More Democratic Political Economy Response to the Columbia Law Review’s 2018 Symposium. Columbia Law Review, 118(7), 179-206.

Morreim, E. H. (2004). Litigation in clinical research: malpractice doctrines versus research realities. Journal of Law, Medicine & Ethics, 32(3), 474-484.

Presidential Commission for the Study of Bioethical Issues. (2014). Moral Science: Protecting Participants in Human Subjects Research. (n.p.). CreateSpace Independent Publishing Platform.

Richardson, L. S. (2008). When human experimentation is criminal. J. Crim. L. & Criminology, 99, 89. 

Smith, A. C., Yandle, B. (2014). Bootleggers & Baptists: How Economic Forces and Moral Persuasion Interact to Shape Regulatory Politics. United States: Cato Institute.

“The Entire History of You.” Black Mirror. Season1, episode 3. Zeppotron, 2011. Netflix,<https://www.netflix.com/watch/70264856>

United States: Office of Inspector General. (1994). Follow-up Review of Possible Improper Pre-approval Promotion Activities.